stockrowDianthus Therapeutics, Inc.
DNTH Healthcare Biotechnology
Dianthus Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 million, down 67.3% from fiscal 2024.
- Revenue
- +205.6%
- EPS
- +16.1%
- Free cash flow
- −65.9%
Quarter to September 2026, against a year earlier
Follow DNTH
Alert me
Dianthus Therapeutics, Inc. (DNTH) Operating margin
Dianthus Therapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was −8,683.9%, up 55.5 percentage points from fiscal 2025 (−8,739.3%). Over the past ten years it has ranged from −8,739.3% (fiscal 2025) to 0.00% (fiscal 2021) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −8,739.3% | (7,105.60) |
| FY2024 | −1,633.7% | 70.93 |
| FY2023 | −1,704.7% | (1,241.76) |
| FY2022 | −462.9% | (462.91) |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −4,832.4% | 3,246.71 |
| Jun 2026 | −8,079.1% | 1,971.21 |
| Mar 2026 | −10,050.3% | 14,435.95 |
| Dec 2025 | −24,486.3% | (14,312.53) |
| 33 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| COGT Cogent Biosciences, Inc. compare | 0.00% |
| MANE Veradermics Incorporated compare | 0.00% |
| ERAS Erasca, Inc. compare | 0.00% |
| DFTX Definium Therapeutics, Inc. compare | 0.00% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| LEGN Legend Biotech Corporation Sponsored ADR compare | −5.06% |
| TVTX Travere Therapeutics, Inc. compare | −20.5% |
| CRSP CRISPR Therapeutics AG compare | −2,114.8% |
| DNTH Dianthus Therapeutics, Inc. | −8,683.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on DNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Altman Z-score
- Beneish M-score
- The full statement